Apyx Medical Corporation (APYX)

NASDAQ: APYX · Real-Time Price · USD

2.950

+0.020 (0.68%)

At close: Nov 9, 2026, 4:00 PM EST

2.890

-0.060 (-2.03%)

After-hours: Nov 9, 2026, 4:17 PM EST

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.78	31.74	31.74	43.65	10.19	30.87
Cash & Short-Term Investments	25.78	31.74	31.74	43.65	10.19	30.87
Cash Growth	2.55%	-0.00%	-27.29%	328.30%	-66.98%	-26.35%
Accounts Receivable	14.87	16.88	15.58	14.12	10.7	13.14
Other Receivables	-	-	-	-	7.64	8.13
Receivables	14.87	16.88	15.58	14.12	18.35	21.26
Inventory	11.95	8.6	7.56	9.92	11.8	6.78
Prepaid Expenses	1.24	1.25	1.56	2.66	2.64	1.83
Total Current Assets	53.84	58.47	56.44	70.36	42.97	60.74
Property, Plant & Equipment	6.09	6.62	6.74	7.15	7.59	6.87
Other Long-Term Assets	1.74	1.75	1.66	1.73	1.22	1.11
Total Assets	61.67	66.84	64.84	79.24	51.78	68.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.51	3.06	2.62	2.71	2.67	2.63
Accrued Expenses	6.87	4.87	3.46	5.21	3.78	6.69
Current Portion of Leases	0.49	0.43	0.36	0.37	0.25	0.29
Current Unearned Revenue	-	0.64	0.69	0.49	0.85	0.53
Other Current Liabilities	-	2.7	3.6	3.97	4.3	3.07
Total Current Liabilities	10.87	11.7	10.72	12.74	11.85	13.21
Long-Term Debt	35.57	34.85	33.89	33.19	-	-
Long-Term Leases	3.69	4.06	4.52	4.95	0.54	0.02
Long-Term Unearned Revenue	1.17	1.05	1.12	1.25	1.41	1.32
Other Long-Term Liabilities	0.34	0.35	0.26	0.2	0.18	0.17
Total Liabilities	51.63	52.01	50.51	52.32	13.98	14.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.04	0.04	0.04	0.04	0.04	0.03
Additional Paid-In Capital	105.85	103.62	92.08	81.11	73.28	66.22
Retained Earnings	-96.26	-89.12	-77.91	-54.45	-35.74	-12.55
Total Common Equity	9.63	14.54	14.21	26.7	37.58	53.7
Minority Interest	0.41	0.29	0.13	0.22	0.21	0.31
Shareholders' Equity	10.04	14.83	14.34	26.92	37.79	54.01
Total Liabilities & Equity	61.67	66.84	64.84	79.24	51.78	68.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	39.75	39.34	38.76	38.5	0.8	0.31
Net Cash (Debt)	-13.97	-7.6	-7.02	5.15	9.4	30.57
Net Cash Growth	-	-	-	-45.18%	-69.26%	-25.88%
Net Cash Per Share	-0.32	-0.18	-0.20	0.15	0.27	0.89
Filing Date Shares Outstanding	42.12	41.83	37.79	34.64	34.6	34.43
Total Common Shares Outstanding	42.12	41.79	37.79	34.64	34.6	34.41
Working Capital	42.97	46.77	45.72	57.62	31.12	47.53
Book Value Per Share	0.23	0.35	0.38	0.77	1.09	1.56
Tangible Book Value	9.63	14.54	14.21	26.7	37.58	53.7
Tangible Book Value Per Share	0.23	0.35	0.38	0.77	1.09	1.56
Land	-	-	-	-	1.6	1.6
Buildings	-	-	-	-	4.43	4.43
Machinery	-	6.14	5.06	4.83	5.09	5.04
Construction In Progress	-	0.16	0.64	0.4	0.51	0.65
Leasehold Improvements	-	0.36	0.28	0.21	0.18	0.17

SEC Filings: 10-K · 10-Q